|
ZCCHC7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.587900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.854310E-02 |
| Normal-vs-Stage2 |
4.067600E-02 |
| Normal-vs-Stage3 |
1.178230E-02 |
| Normal-vs-Stage4 |
1.96509999994543E-06 |
| Stage1-vs-Stage2 |
6.823200E-01 |
| Stage1-vs-Stage3 |
1.243980E-01 |
| Stage1-vs-Stage4 |
2.260400E-03 |
| Stage2-vs-Stage3 |
2.794200E-01 |
| Stage2-vs-Stage4 |
1.057720E-02 |
| Stage3-vs-Stage4 |
2.032400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.343870E-03 |
| Normal-vs-AfricanAmerican |
6.664400E-03 |
| Normal-vs-Asian |
6.518100E-02 |
| Caucasian-vs-AfricanAmerican |
6.522200E-01 |
| Caucasian-vs-Asian |
8.049200E-01 |
| AfricanAmerican-vs-Asian |
9.410800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.521700E-03 |
| Normal-vs-Female |
1.033640E-04 |
| Male-vs-Female |
4.334200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.640700E-03 |
| Normal-vs-Extreme_Weight |
2.935900E-02 |
| Normal-vs-Obese |
1.440060E-03 |
| Normal-vs-Extreme_Obese |
7.489400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.164220E-01 |
| Normal_Weight-vs-Obese |
7.156200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.644040E-01 |
| Extreme_Weight-vs-Obese |
1.167000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.899000E-01 |
| Obese-vs-Extreme_Obese |
1.604000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.055600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.20309999999779E-05 |
| Normal-vs-Age(61-80Yrs) |
5.189800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.046600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.255200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.471700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.606230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.961300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.314000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.004200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.632600E-04 |
| Normal-VS-Type2 PRCC |
3.909400E-01 |
| Normal-VS-KIRP CIMP |
8.101200E-03 |
| Normal-VS-Unclassified PRCC |
3.376200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.020470E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.586400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.301800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.148010E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.215640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.646100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.516190E-01 |
| Normal-vs-N1 |
2.200000E-03 |
| Normal-vs-N2 |
1.853770E-01 |
| N0-vs-N1 |
1.352360E-02 |
| N0-vs-N2 |
6.477800E-01 |
| N1-vs-N2 |
3.990800E-01 |
|
|
